DarioHealth Corp Net Assets
DarioHealth Corp net assets. Based on the latest financial reports, DarioHealth Corp (DRIO) has net assets worth $55.09 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($96.59 Million) and total liabilities ($41.50 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore DarioHealth Corp (DRIO) equity growth momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $55.09 Million |
| % of Total Assets | 57.03% |
| Annual Growth Rate | N/A |
| 5-Year Change | -20.6% |
| 10-Year Change | N/A |
| Growth Volatility | 322.61 |
Net Assets of DarioHealth Corp (2012–2025)
Net assets of DarioHealth Corp from 2012 to 2025. This chart illustrates how DarioHealth Corp's net assets have evolved over time, based on quarterly financial data. See DRIO net asset quality score to measure how much of total assets are equity-financed.
Annual Net Assets for DarioHealth Corp (2012–2025)
The table below shows the annual net assets of DarioHealth Corp from 2012 to 2025. For live market cap and overall valuation, see DRIO market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $67.92 Million | -5.69% |
| 2024-12-31 | $72.02 Million | +23.86% |
| 2023-12-31 | $58.14 Million | -27.32% |
| 2022-12-31 | $80.00 Million | -6.49% |
| 2021-12-31 | $85.55 Million | +203.89% |
| 2020-12-31 | $28.15 Million | +48.99% |
| 2019-12-31 | $18.89 Million | +111.70% |
| 2018-12-31 | $8.93 Million | +126.47% |
| 2017-12-31 | $3.94 Million | +160.25% |
| 2016-12-31 | $-6.54 Million | -941.83% |
| 2015-12-31 | $777.00K | +130.61% |
| 2014-12-31 | $-2.54 Million | -2838.15% |
| 2013-12-31 | $-86.38K | +91.92% |
| 2012-12-31 | $-1.07 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to DarioHealth Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 44600607800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
DarioHealth Corp Net Assets Breakdown (December 2025)
DarioHealth Corp net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $4.00K | 0.01% |
| Other Components | $520.00 Million | 765.58% |
| Total Equity | $67.92 Million | 100.00% |
DarioHealth Corp Competitors by Market Cap
The table below lists competitors of DarioHealth Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Carbochim SA
RO:CBC
|
$29.40 Million |
|
Shankara Building Products Limited
NSE:SHANKARA
|
$29.43 Million |
|
IMCO Industries Ltd
TA:IMCO
|
$29.44 Million |
|
Monks Investment Trust PLC
LSE:MNKS
|
$29.45 Million |
|
Klimasan Klima Sanayi ve Ticaret AS
IS:KLMSN
|
$29.39 Million |
|
Klondike Gold Corp
V:KG
|
$29.38 Million |
|
Taya Inv-L
TA:TAYA
|
$29.38 Million |
|
Karolinska Development AB ser. B
ST:KDEV
|
$29.36 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in DarioHealth Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 72,019,000 to 67,922,000, a change of -4,097,000 (-5.7%).
- Net loss of 41,714,000 reduced equity.
- New share issuances of 24,128,000 increased equity.
- Other factors increased equity by 13,489,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-41.71 Million | -61.41% |
| Share Issuances | $24.13 Million | +35.52% |
| Other Changes | $13.49 Million | +19.86% |
| Total Change | $- | -5.69% |
Book Value vs Market Value Analysis
This analysis compares DarioHealth Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.19x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | $-96.39 | $3.00 | x |
| 2013-12-31 | $-8.49 | $3.00 | x |
| 2014-12-31 | $-105.28 | $3.00 | x |
| 2015-12-31 | $8.19 | $3.00 | x |
| 2016-12-31 | $-25.14 | $3.00 | x |
| 2017-12-31 | $8.19 | $3.00 | x |
| 2018-12-31 | $7.62 | $3.00 | x |
| 2019-12-31 | $8.34 | $3.00 | x |
| 2020-12-31 | $4.72 | $3.00 | x |
| 2021-12-31 | $5.16 | $3.00 | x |
| 2022-12-31 | $3.38 | $3.00 | x |
| 2023-12-31 | $2.05 | $3.00 | x |
| 2024-12-31 | $1.78 | $3.00 | x |
| 2025-12-31 | $1.37 | $3.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently DarioHealth Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -61.41%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -186.56%
- • Asset Turnover: 0.20x
- • Equity Multiplier: 1.62x
- Recent ROE (-61.41%) is above the historical average (-150.50%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-5.58 Million |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $-13.92 Million |
| 2014 | 0.00% | -25249.02% | 0.02x | 0.00x | $-12.62 Million |
| 2015 | -919.18% | -867.80% | 0.16x | 6.53x | $-7.22 Million |
| 2016 | 0.00% | -388.41% | 0.72x | 0.00x | $-10.23 Million |
| 2017 | -399.47% | -304.51% | 0.74x | 1.77x | $-16.14 Million |
| 2018 | -199.47% | -240.78% | 0.52x | 1.58x | $-18.70 Million |
| 2019 | -93.87% | -234.63% | 0.31x | 1.30x | $-19.63 Million |
| 2020 | -104.60% | -388.66% | 0.21x | 1.26x | $-32.26 Million |
| 2021 | -89.73% | -374.21% | 0.20x | 1.18x | $-85.32 Million |
| 2022 | -77.74% | -224.88% | 0.23x | 1.49x | $-70.19 Million |
| 2023 | -102.21% | -292.00% | 0.21x | 1.66x | $-65.24 Million |
| 2024 | -59.36% | -158.09% | 0.23x | 1.65x | $-49.95 Million |
| 2025 | -61.41% | -186.56% | 0.20x | 1.62x | $-48.51 Million |
Industry Comparison
This section compares DarioHealth Corp's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $420,718,148
- Average return on equity (ROE) among peers: -115.97%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| DarioHealth Corp (DRIO) | $55.09 Million | 0.00% | 0.75x | $29.40 Million |
| Aclarion Inc (ACON) | $-728.00K | 0.00% | 0.00x | $1.02 Million |
| American Well Corp (AMWL) | $1.26 Billion | -13.99% | 0.15x | $133.17 Million |
| Heartbeam Inc (BEAT) | $-26.87 Million | 0.00% | 0.00x | $24.24 Million |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG) | $-540.52K | 0.00% | 0.00x | $5.96 Million |
| BrightSpring Health Services, Inc. Common Stock (BTSG) | $612.55 Million | -25.24% | 8.03x | $10.63 Billion |
| Carlsmed, Inc. (CARL) | $98.87 Million | -29.97% | 0.32x | $393.16 Million |
| CareCloud, Inc. (CCLD) | $406.08K | 28.81% | 7.58x | $73.09 Million |
| Certara Inc (CERT) | $492.05 Million | -1.81% | 1.11x | $1.12 Billion |
| CareMax Inc (CMAX) | $61.44 Million | -1112.15% | 9.14x | $381.50 |
| Claritev Corporation (CTEV) | $1.71 Billion | -5.37% | 3.08x | $358.00 Million |
About DarioHealth Corp
DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to crea… Read more